Beam Therapeutics
BEAM
BEAM
215 hedge funds and large institutions have $1.84B invested in Beam Therapeutics in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 82 increasing their positions, 66 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
215
Holders Change
-22
Holders Change %
-9.28%
% of All Funds
2.88%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
35
Increased
82
Reduced
66
Closed
55
Calls
$14.1M
Puts
$37.3M
Net Calls
-$23.2M
Net Calls Change
-$27.2M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$85.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.2M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$13.9M |
| 4 |
Goldman Sachs
New York
|
+$10.3M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$10.1M |
Top Sellers
| 1 |
Temasek Holdings
Singapore
|
-$35.4M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$29.1M |
| 3 |
DM
Deerfield Management
New York
|
-$17.1M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$10.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.93M |